Southern Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.76M	Buy	28,186 +4,833	+21%	+$826K	2.23%	12
2025 Q4	$3.94M	Buy	23,353 +871	+4%	+$141K	1.82%	16
2025 Q3	$3.25M	Buy	22,482 +20,283	+922%	+$2.77M	1.52%	19
2025 Q2	$278K	Hold	2,199	–	–	0.14%	67
2025 Q1	$281K	Buy	2,199 +2	+0.1%	+$271	0.16%	63
2024 Q4	$290K	Buy	2,197 +1	+0%	+$141	0.16%	55
2024 Q3	$320K	Buy	2,196 +3	+0.1%	+$434	0.18%	50
2024 Q2	$301K	Hold	2,193	–	–	0.19%	52
2024 Q1	$301K	Buy	2,193 +2	+0.1%	+$273	0.18%	53
2023 Q4	$298K	Sell	2,191 -1,421	-39%	-$173K	0.21%	47
2023 Q3	$442K	Hold	3,612	–	–	0.37%	38
2023 Q2	$459K	Sell	3,612 -11,695	-76%	-$1.52M	0.35%	39
2023 Q1	$1.98M	Buy	15,307 +2,346	+18%	+$307K	1.46%	17
2022 Q4	$1.7M	Buy	12,961 +491	+4%	+$63.5K	1.32%	19
2022 Q3	$1.46M	Sell	12,470 -2,491	-17%	-$309K	1.19%	18
2022 Q2	$1.76M	Buy	14,961 +12,822	+599%	+$1.52M	1.4%	18
2022 Q1	$279K	Sell	2,139 -22,533	-91%	-$2.94M	0.19%	60
2021 Q4	$3.77M	Buy	+24,672	New	+$3.82M	2.33%	11